Trial0

Clinical trial · NCT07051239 · NOT_YET_RECRUITING · NA

Sleep Stimulation to Enhance Waste Clearance in the Brain

Sponsor: Erasme University Hospital

We save this real registry record and notify you if its published status changes. Create an account to add profile details that improve future matching.

Summary

This study aims to examine whether multi-night closed-loop auditory stimulation (CLAS) during sleep can enhance waste clearance and memory consolidation in healthy adults and older adults with subjective cognitive decline or mild cognitive impairment who exhibit elevated brain amyloid levels identified through prior clinical screening. Specifically, the study investigates whether sleep stimulation increases the clearance of plasma biomarkers related to neurodegeneration, improves the brain's waste clearance system, and supports memory consolidation. Participants will undergo five nights each of CLAS and sham (no stimulation) interventions, with a washout period in between. They will also complete clinical assessments, including MRI scans, blood sample collection, and cognitive testing, and will keep track of subjective sleep quality, sleepiness, mood, and fatigue throughout the interventions.

Interventions

  • Closed-loop acoustic stimulation · OTHER

    At-home sleep will be monitored using an EEG headband. Non-awakening auditory stimuli will be delivered during non-rapid eye movement sleep (NREM), timed to the ascending phase of slow waves, using either active or control (sham) conditions.

Published eligibility criteria

Verbatim from the registry. Only the site can decide how these apply to a specific patient.

For the positive amyloid load group:

-Participants who meet the criteria of subjective cognitive decline or mild cognitive impairment (Clinical Dementia Rating \< 2; Mini-Mental State Examination ≥ 21) and brain amyloid-beta (Aβ) accumulation confirmed by CSF or amyloid-PET, the inclusion age range is 55-80 years.

For healthy groups:

-Inclusion age range is 18-80 years.

Inclusion criteria:

* Proficiency in the French language (close to native level) to complete the neuropsychological evaluation and cognitive tests.
* MRI compatibility: absence of metallic materials in the body (implants, vascular clips, certain types of orthopedic material, etc.), a pacemaker or other types of stimulators, cochlear implants, or any other electronic devices.

Exclusion criteria:

* Current or past psychiatric or neurological conditions (except for those directly associated with the patient group).
* The presence of severe untreated sleep disorders.
* The presence of irregular sleep-wake cycles (due to shiftwork or extreme chronotype).
* The presence of moderate depression or high levels of anxiety.
* Ongoing treatment with psychotropic medications (benzodiazepines, antidepressants).
* Regular or excessive consumption of alcohol or caffeinated drinks.
* Consumption of other psychoactive substances known to have an impact on the central nervous system.
* Insufficient visual or auditory acuity to complete the assessments if uncorrected. Normal hearing is required for sound stimulation to be effective.
* Claustrophobia that prevents undergoing brain imaging (MRI).
* Pregnancy or currently breastfeeding

Sites (1)

  • Hôpital Universitaire de Bruxelles, Brussels, Belgium

Not medical advice. Trial0 is a navigation service, not a medical provider. Nothing here is medical advice or a recommendation to pursue any treatment; eligibility matching is informational, based on published registry criteria, and only the trial site or treating clinician can determine actual eligibility. Decisions belong with the patient and their own doctors. Registry data refreshed at most hourly; last update posted 2025-07-09.